Bigfoot Biomedical Stock

Medical Device Company

Sign up today and learn more about Bigfoot Biomedical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Cormorant Asset Management


Milpitas CA, US

Total Funding


About Bigfoot Biomedical Stock

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.


Abbott Biotech Ventures

Bigfoot Biomedical

Cormorant Asset Management

Freenome, Bigfoot Biomedical

Janus Capital Group

Bigfoot Biomedical


Bigfoot Biomedical

Quadrant Capital Advisors

Bigfoot Biomedical

Senvest Capital

Spotify, Bigfoot Biomedical

Funding History

November 2014$2.0M
October 2016$35.5M
December 2017$37.0M
March 2018$18.0M
January 2020$45.0M


Chief Executive Officer

Brewer Jeffrey

Chief Financial Officer

Brett Hale

Chief Operating Officer

Ian Hanson


drugdeliverybusiness - Jan, 7 2019

Bigfoot Biomedical inks insulin deal with Eli Lilly

medicaldesignandoutsourcing - Dec, 22 2017

7 top stories that mattered for medtech in 2017

continuuminnovation - Dec, 20 2017

Mission Control

medicaldesignandoutsourcing - Jul, 26 2016

Ones to Watch, ten companies we’re keeping an eye on

discovermagazine - Apr, 24 2016

Artificial Pancreas Makers Race to Market

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: